LOUIS C. BOCK

Profile

First Name

: LOUIS

Middle Name

: C.

Last Name

: BOCK

Related Companies

Titles

Company Name

Related People

DIRECTOR

JAMES C. BLAIR, STEPHEN J. FARR, CAM GARNER, CAM L. GARNER, KEN HAAS, J.D. HALDEMAN, ROGER L. HAWLEY, ERLE T. MAST, ARDA M. MINOCHERHOMJEE, ARDA M. MINOCHERHOMJEE, PH.D., DAVID W. NASSIF, ANN D. RHOADS, CYNTHIA Y. ROBINSON, KURT C. WHEELER, ALEX ZISSON

DIRECTOR

HORIZON THERAPEUTICS INC

JEFFREY W. BIRD, ROBERT J. DE VAERE, BARRY L. GOLOMBIK, JEFF HIMAWAN, JEFFREY W. SHERMAN, GEORGE F. TIDMARSH, TIMOTHY P. WALBERT

DIRECTOR

SCALE VENTURE PARTNERS III, L.P.

MARK J. BROOKS, JIM J. JONES, KATE D. MITCHELL, RORY T. O-DRISCOLL, C/O SCALE VENTURES SCALE VENTURE MANAGEMENT III, LLC, ROBERT I. THEIS, SHARON L. WEINBAR

DIRECTOR

SONEXA THERAPEUTICS INC

ROBERT ALEXANDER, KIM PULOMA KAMDAR, LYNNE ROLLINS, ECKARD WEBER, M.D.

DIRECTOR

HORIZON PHARMA, INC.

JEFFREY W. BIRD, HUBERT BIRNER, ROBERT DE VAERE, JEAN-FRANCOIS FORMELA, MICHAEL GREY, JEFF HIMAWAN, PETER JOHANN, RONALD PAULI, GINO SANTINI, TIMOTHY P. WALBERT

DIRECTOR

BERNARD M. ALFANO, DAVID J. FOSTER, JAMES P. PANEK, CHARLES W. PATRICK, PATRICK PLEWMAN, LORI F. RAFIELD, ROBERT L. WOLFERT

DIRECTOR

SONEXA THERAPEUTICS, INC

ROBERT ALEXANDER, KIM PULOMA KAMDAR, LYNNE ROLLINS, ECKARD WEBER, M.D.

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2012-08-01

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2012-03-29

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2012-03-02

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2012-02-22

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

2011-10-07

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2011-06-02

D/A

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity, Debt

2010-04-01

D/A

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity, Debt

2010-04-01

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2010-07-28

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Debt

2010-07-01

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity, Debt

2010-04-01

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2010-04-01

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2008-01-15

D

PHARMACEUTICALS

DECLINE TO DISCLOSE

Equity

2009-12-07

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2008-10-28

D

VENTURE CAPITAL FUND

DECLINE TO DISCLOSE

2008-06-26

D/A

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2009-09-22

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2009-09-22

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Debt

2009-07-17

D/A

PHARMACEUTICALS

DECLINE TO DISCLOSE

Debt

2008-10-28

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Debt

2009-06-15

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Debt

2009-05-15